Abstract
We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.
| Original language | English |
|---|---|
| Article number | 93 |
| Journal | Trials |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Dec 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 16 Peace, Justice and Strong Institutions
Keywords
- Clinical trials
- Outcomes
- Patient and public involvement/PPI
- Trial methodology
Fingerprint
Dive into the research topics of 'Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver